author-photo

Karin Berghoff

National Patient Safety Foundation

2

Papers

4

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression.

2021 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (2)
Phase 1b/2 trial of tepotinib in sorafenibpretreated advanced hepatocellular carcinoma with MET overexpression

2021 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (2)